These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26621801)

  • 41. Effect of mite allergenic components on innate immune response: Synergy of protease (Group 1 & 3) and non-protease (Group 2 & 7) allergens.
    Yin SC; Liao EC; Ye CX; Chang CY; Tsai JJ
    Immunobiology; 2018; 223(6-7):443-448. PubMed ID: 29398016
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-affinity IgG to a major A. fumigatus allergen, Asp f 2, retards allergic response.
    Svirshchevskaya EV; Viskova N; Shevchenko M; Alekseeva L; Marchenko A; Benevolensky S; Kurup VP
    Med Sci Monit; 2004 Oct; 10(10):BR371-80. PubMed ID: 15448590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intranasal immunization with a dominant T-cell epitope peptide of a major allergen of olive pollen prevents mice from sensitization to the whole allergen.
    Marazuela EG; Rodríguez R; Fernández-García H; García MS; Villalba M; Batanero E
    Mol Immunol; 2008 Jan; 45(2):438-45. PubMed ID: 17662454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
    Möbs C; Ipsen H; Mayer L; Slotosch C; Petersen A; Würtzen PA; Hertl M; Pfützner W
    J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recombinant allergen and peptide-based approaches for allergy prevention by oral tolerance.
    Campana R; Huang HJ; Freidl R; Linhart B; Vrtala S; Wekerle T; Karaulov A; Valenta R
    Semin Immunol; 2017 Apr; 30():67-80. PubMed ID: 28939389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy.
    Wiedermann U; Jahn-Schmid B; Lindblad M; Rask C; Holmgren J; Kraft D; Ebner C
    Int Immunol; 1999 Oct; 11(10):1717-24. PubMed ID: 10508191
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nisin-induced expression of recombinant T cell epitopes of major Japanese cedar pollen allergens in Lactococcus lactis.
    Van Hoang V; Ochi T; Kurata K; Arita Y; Ogasahara Y; Enomoto K
    Appl Microbiol Biotechnol; 2018 Jan; 102(1):261-268. PubMed ID: 29094185
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.
    Vrtala S; Akdis CA; Budak F; Akdis M; Blaser K; Kraft D; Valenta R
    J Immunol; 2000 Dec; 165(11):6653-9. PubMed ID: 11086111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo and in vitro immunomodulation of Der p 1 allergen-specific response by Lactobacillus plantarum bacteria.
    Hisbergues M; Magi M; Rigaux P; Steuve J; Garcia L; Goudercourt D; Pot B; Pestel J; Jacquet A
    Clin Exp Allergy; 2007 Sep; 37(9):1286-95. PubMed ID: 17845408
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA vaccine encoding Der p 2 allergen generates immunologic protection in recombinant Der p 2 allergen-induced allergic airway inflammation mice model.
    Li GP; Liu ZG; Qiu J; Ran PX; Zhong NS
    Chin Med J (Engl); 2005 Apr; 118(7):534-40. PubMed ID: 15820083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation of an allergy vaccine by disruption of the three-dimensional structure of the cross-reactive calcium-binding allergen, Phl p 7.
    Westritschnig K; Focke M; Verdino P; Goessler W; Keller W; Twardosz A; Mari A; Horak F; Wiedermann U; Hartl A; Thalhamer J; Sperr WR; Valent P; Valenta R
    J Immunol; 2004 May; 172(9):5684-92. PubMed ID: 15100313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Allergy therapy by intranasal administration with recombinant Lactococcus lactis Producing bovine beta-lactoglobulin.
    Cortes-Perez NG; Ah-Leung S; Bermúdez-Humarán LG; Corthier G; Langella P; Wal JM; Adel-Patient K
    Int Arch Allergy Immunol; 2009; 150(1):25-31. PubMed ID: 19339799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of local nasal immunotherapy in allergic airway inflammation: Using urea denatured Dermatophagoides pteronyssinus.
    Yu SJ; Liao EC; Tsai JJ
    Hum Vaccin Immunother; 2015; 11(4):915-21. PubMed ID: 25933184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Airway inflammation induced after allergic poly-sensitization can be prevented by mucosal but not by systemic administration of poly-peptides.
    Hufnagl K; Focke M; Gruber F; Hufnagl P; Loupal G; Scheiner O; Wiedermann U
    Clin Exp Allergy; 2008 Jul; 38(7):1192-202. PubMed ID: 18462454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intralymphatic injections as a new administration route for allergen-specific immunotherapy.
    Martínez-Gómez JM; Johansen P; Erdmann I; Senti G; Crameri R; Kündig TM
    Int Arch Allergy Immunol; 2009; 150(1):59-65. PubMed ID: 19339803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A recombinant allergen chimer as novel mucosal vaccine candidate for prevention of multi-sensitivities.
    Wild C; Wallner M; Hufnagl K; Fuchs H; Hoffmann-Sommergruber K; Breiteneder H; Scheiner O; Ferreira F; Wiedermann U
    Allergy; 2007 Jan; 62(1):33-41. PubMed ID: 17156339
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppression of allergen-specific B lymphocytes by chimeric protein-engineered antibodies.
    Kerekov N; Michova A; Muhtarova M; Nikolov G; Mihaylova N; Petrunov B; Nikolova M; Tchorbanov A
    Immunobiology; 2014 Jan; 219(1):45-52. PubMed ID: 24021574
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intramuscular immunization with DNA construct containing Der p 2 and signal peptide sequences primed strong IgE production.
    Tan LK; Huang CH; Kuo IC; Liew LM; Chua KY
    Vaccine; 2006 Jul; 24(29-30):5762-71. PubMed ID: 16740347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses.
    Takagi H; Hiroi T; Yang L; Tada Y; Yuki Y; Takamura K; Ishimitsu R; Kawauchi H; Kiyono H; Takaiwa F
    Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17525-30. PubMed ID: 16278301
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevention of allergic asthma by vaccination with transgenic rice seed expressing mite allergen: induction of allergen-specific oral tolerance without bystander suppression.
    Suzuki K; Kaminuma O; Yang L; Takai T; Mori A; Umezu-Goto M; Ohtomo T; Ohmachi Y; Noda Y; Hirose S; Okumura K; Ogawa H; Takada K; Hirasawa M; Hiroi T; Takaiwa F
    Plant Biotechnol J; 2011 Dec; 9(9):982-90. PubMed ID: 21447056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.